Skip to content

Cellectar Biosciences, Inc.: 10-K filed 2013-03-28

What Cellectar Biosciences, Inc. reported in its annual report filed 2013-03-28 (fiscal FY 2012): 34 published measures, 105 facts as tagged in accession 0001144204-13-018332.

This filing

Form
10-K (annual report)
Filed
2013-03-28
Fiscal period
fiscal FY 2012
Accession
0001144204-13-018332 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cellectar Biosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3111,478,164USD
At 2011-12-3110,563,176USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3110,158,375USD
At 2011-12-319,481,123USD
At 2010-12-31133,762USD
At 2009-12-314,126,893USD
At 2008-12-319,844,567USD
At 2007-12-312,526,232USD
At 2006-12-316,546,165USD
At 2005-12-31400,206USD
At 2004-12-3146,175USD
At 2003-12-31388,936USD
At 2002-12-31599,377USD
At 2002-11-060USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-314,677,545USD
At 2011-12-315,505,960USD
At 2010-12-31673,739USD
At 2002-11-060USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-8,796,974USD366
2002-11-07 to 2012-12-31-40,277,400USD3708
2011-01-01 to 2011-12-31-7,435,422USD365
2010-01-01 to 2010-12-31-4,560,263USD365
2009-01-01 to 2009-12-31-6,219,873USD365
2008-01-01 to 2008-12-31-6,090,715USD366
2007-01-01 to 2007-12-31-5,090,325USD365
2006-01-01 to 2006-12-31-963,440USD365
2005-01-01 to 2005-12-31-481,837USD365
2004-01-01 to 2004-12-31-342,761USD366
2003-01-01 to 2003-12-31-295,790USD365
2002-11-07 to 2002-12-310USD55

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-6,585,024USD366
2002-11-07 to 2012-12-31-31,717,730USD3708
2011-01-01 to 2011-12-31-5,970,090USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-3197,691USD366
2002-11-07 to 2012-12-315,584,283USD3708
2011-01-01 to 2011-12-31118,411USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-317,854,300USD366
2002-11-07 to 2012-12-3143,141,580USD3708
2011-01-01 to 2011-12-319,515,073USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-2,097,691USD366
2002-11-07 to 2012-12-31-6,746,305USD3708
2011-01-01 to 2011-12-311,287,238USD365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-31933,573USD366
2011-01-01 to 2011-12-311,106,296USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-312,645,003USD
At 2011-12-313,044,565USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,503,297USD366
2002-11-07 to 2012-12-314,358,170USD3708
2011-01-01 to 2011-12-31907,460USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-8,754,785USD366
2002-11-07 to 2012-12-31-40,021,568USD3708
2011-01-01 to 2011-12-31-7,037,720USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-315,130,477USD
At 2011-12-315,815,927USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31732,691USD
At 2011-12-31503,581USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-12-311,675,462USD
At 2011-12-311,675,462USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2002-11-07 to 2012-12-3131,667USD3708
2011-01-01 to 2011-12-310USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,122,686USD366
2002-11-07 to 2012-12-3125,927,725USD3708
2011-01-01 to 2011-12-313,599,080USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3146,397,997shares
At 2011-12-3136,907,824shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3150,435,311USD
At 2011-12-3140,961,180USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-12-31450,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-315,493,055USD
At 2011-12-315,398,561USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-312,848,052USD
At 2011-12-312,353,996USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-3127,222USD
At 2011-12-3127,222USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31327,393USD
At 2011-12-31254,967USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-3139,347,745USD
At 2011-12-3138,414,172USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-9,340,333USD366
2002-11-07 to 2012-12-31-40,820,759USD3708
2011-01-01 to 2011-12-31-7,435,422USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,632,099USD366
2002-11-07 to 2012-12-3113,294,710USD3708
2011-01-01 to 2011-12-312,692,433USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-31497,000USD366
2011-01-01 to 2011-12-31585,000USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31497,253USD366
2002-11-07 to 2012-12-312,913,291USD3708
2011-01-01 to 2011-12-31584,841USD365
2010-01-01 to 2010-12-31580,114USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2002-11-07 to 2012-12-311,161USD3708
2011-01-01 to 2011-12-310USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-42,189USD366
2002-11-07 to 2012-12-31-255,832USD3708
2011-01-01 to 2011-12-31-397,702USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-310USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-933,573USD366
2011-01-01 to 2011-12-31-1,106,296USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,838,774USD366
2002-11-07 to 2012-12-3138,713,028USD3708
2011-01-01 to 2011-12-3110,164,546USD365
2002-11-07 to 2011-04-0821,710,000USD3075

Inspect the source

Entity
Cellectar Biosciences, Inc. / CIK 0001279704
Captured
2026-09-20T07:48:31.991Z
SEC response SHA-256
44da00fed89c835867d9290b98319109f07ad849957763fd081353f99891a212

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001279704.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))